mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.01 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |